Search by Drug Name or NDC
NDC 00006-3856-02 RECARBRIO 500; 500; 250 mg/100mL; mg/100mL; mg/100mL Details
RECARBRIO 500; 500; 250 mg/100mL; mg/100mL; mg/100mL
RECARBRIO is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS.
MedlinePlus Drug Summary
Imipenem, cilastatin, and relebactam injection is used to treat adults with certain serious urinary tract infections including kidney infections, and certain serious abdominal (stomach) infections when there are few or no other treatment options. It is also used to treat certain types of pneumonia that developed in adults who are on ventilators or who were already in a hospital. Imipenem is in a class of medications called carbapenem antibiotics. It works by killing bacteria. Cilastatin is in a class of medications called dehydropeptidase inhibitors. It works by helping imipenem stay active in your body for a longer period of time. Relebactam is in a class of medications called beta-lactamase inhibitors. It works by preventing bacteria from destroying imipenem. Antibiotics such as imipenem, cilastatin, and relebactam injection will not work for colds, flu, or other viral infections. Taking or using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 00006-3856-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Imipenem, Cilastatin, and Relebactam Injection
Product Information
NDC | 00006-3856 |
---|---|
Product ID | 0006-3856_8a65f15d-ca70-46ce-b575-7a1b5092a243 |
Associated GPIs | 16159903402120 |
GCN Sequence Number | 080066 |
GCN Sequence Number Description | imipenem/cilastatin/relebactam VIAL 1.25 G INTRAVEN |
HIC3 | W1S |
HIC3 Description | CARBAPENEM ANTIBIOTICS (THIENAMYCINS) |
GCN | 46743 |
HICL Sequence Number | 045883 |
HICL Sequence Number Description | IMIPENEM/CILASTATIN SODIUM/RELEBACTAM |
Brand/Generic | Brand |
Proprietary Name | RECARBRIO |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | imipenem anhydrous, cilastatin, and relebactam anhydrous |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, POWDER, FOR SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 500; 500; 250 |
Active Ingredient Units | mg/100mL; mg/100mL; mg/100mL |
Substance Name | CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS |
Labeler Name | Merck Sharp & Dohme LLC |
Pharmaceutical Class | Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA212819 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00006-3856-02 (00006385602)
NDC Package Code | 0006-3856-02 |
---|---|
Billing NDC | 00006385602 |
Package | 25 VIAL, SINGLE-DOSE in 1 CARTON (0006-3856-02) / 20 mL in 1 VIAL, SINGLE-DOSE (0006-3856-01) |
Marketing Start Date | 2020-01-06 |
NDC Exclude Flag | N |
Pricing Information | N/A |